Featured Article
A new study found that internal medicine patients of new doctors with top scores on their board certification exams had a lover risk of dying within seven days of being admitted to the hospital and a lower risk of readmission.
Precision Oncology Today
Magazine
Beginning a New Era of Precision Alzheimer’s Therapeutics
Alzheimer’s is a disease associated with aging and impacts almost seven million people in the U.S. over the age of 65, with women and Black or Hispanic populations disproportionately affected by the condition. Finding an effective treatment for Alzheimer’s disease has proved to be a long and difficult quest.
5 Startups With Proteomics Potential Attracting Investor Cash
Investor appetite is growing for startups that can make proteomics faster, cheaper, and more informative for use in precision medicine. Here are five proteomics...
Trending on Inside Precision Medicine
Altering CAR Proteins Improves T Cells’ Ability to Attack Solid Tumors
Researchers have demonstrated that altering two of the four key proteins in chimeric antigen receptors (CARs) improved their ability to attack and shrink glioblastoma, pancreatic, and lung tumors in mouse models of these cancers.
New Technique Improves T Cell-Based Immunotherapies for Solid Tumors
Scripps Research studies in mice showed that the enhanced proximity of the T cell to its cancer cell target improved T-cell mediated killing of cancer cells.
New Immune Mechanism That Interferes with Checkpoint Inhibitors Revealed
Immune checkpoint inhibitors can be impeded when the ligand B7H6 promotes cytolysis of activated T cells by NK cells.